KR860008157A - 2.5-디아릴 테트라하이드로푸란 및 이의 동족체의 제조방법 - Google Patents

2.5-디아릴 테트라하이드로푸란 및 이의 동족체의 제조방법 Download PDF

Info

Publication number
KR860008157A
KR860008157A KR1019860003097A KR860003097A KR860008157A KR 860008157 A KR860008157 A KR 860008157A KR 1019860003097 A KR1019860003097 A KR 1019860003097A KR 860003097 A KR860003097 A KR 860003097A KR 860008157 A KR860008157 A KR 860008157A
Authority
KR
South Korea
Prior art keywords
trimethoxyphenyl
furanyl
pyridine
compound
dimethoxy
Prior art date
Application number
KR1019860003097A
Other languages
English (en)
Other versions
KR900003372B1 (ko
Inventor
황 산-바오
더불유.도우버 토마스
더블유. 도우버 토마스
알.비티 토마스
알. 비티 토마스
쎈 즁-잉
셴 중-잉
비프튜 테스파에
Original Assignee
머크 앤드 캄파니, 인코포레이티드
제임스 에프. 노우톤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 머크 앤드 캄파니, 인코포레이티드, 제임스 에프. 노우톤 filed Critical 머크 앤드 캄파니, 인코포레이티드
Publication of KR860008157A publication Critical patent/KR860008157A/ko
Application granted granted Critical
Publication of KR900003372B1 publication Critical patent/KR900003372B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/06—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D307/08—Preparation of tetrahydrofuran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

내용 없음

Description

2,5-디아릴 테트라하이드로푸란 및 이의 동족체의 제조방법.
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 하기일반식(Ⅱ) 화합물을 환원제로 처리하거나 ; 하기 일반식(Ⅲ) 화합물을 산화시키거나 ; 하기 일반식(Ⅳ) 화합물을 수성산으로 처리함을 특징으로 하여, 하기 일반식(Ⅰ)의 화합물을 제조하는 방법.
    상기식에서, R 및 R1은 독립적으로 (a) 수소 ; (b) 할로저급알킬 ; (c) 할로 ; (d) CONR2R3[여기에서,R2및 R3는 독립적으로 수소, (C1내지 C8) 알킬, 또는 (C3내지 C8)사이클로 알킬을 나타낸다] ; (e) 저급알케닐 ; (f) -COR2; (g) -CH2OR2; (h) 저급알키닐 ; (i) -CH2NR2R3; (j)-CH2SR2; (k) =O ; (l) -OR2; 또는 (m)-R2이고, Ar 및 Ar1은 각각 동일하거나 상이하며, (a) 일반식의 페닐 또는 치환된 페닐{여기에서, R4내지 R8은 각기 독립적으로H ; R2 ; YO-[여기에서, Y는 저급알케닐, 저급알키닐, -CH2-,-CH2OR2, -CH2(C3내지 C8) 사이클로알킬, -CH2Ar2(여기에서 Ar2는 페닐 또는 치환된 페닐이다), 또는 -CH2-CH(HO)-CH2OH를 나타낸다] ; R2S-(O)n[여기에서, R2는 단지(C3내지 C8)사이클로알킬일 수 있고 n은 0 내지 2이다] ; CF3SO ; CF3SO2; -CONR2R3; -NR2COR3; -OCONH2; -CR2R3R9(여기에서, R9는 R2와 동일하거나 상이하다) ; -CH2OR2; -CH2OCOR3; -CH2O-CO-OR2; -NHCH2COOR2; 할로 ; 또는 N+R2R3R9X-(여기에서 X-는 음이온이다)이다} ; (b) 하나 또는 그 이상의 헤테로원자 N, S, 또는 O를 1개 내지 3개 함유하는 모노헤테로아릴, 디- 또는 폴리헤테로아릴 또는 융합된 헤테로아릴 ; (c) 헤테로아릴알킬 ; (d) 헤테로사이클로알킬 또는 (e) 헤테로사이클로 알케닐이며, A 및 B는 독립적으로 H, 하이드록시-(C1내지 C6)알킬, (C1내지 C6)알콕시 또는 (C1내지 C6)알콕시카보닐이다
  2. 제1항에 있어서, a) 2,3-디메톡시-5-(태트라하이드로-5-(3,4,5-트리메톡시페닐)-2-푸라닐)피리딘 ; b) 2,5-비스(2,3-디메톡시-5-피리딜) 테트라하이드로푸란 ; c) 3-(테트라하이드로-5-(3,4,5-트리메톡시페닐)-2-푸란)피리딘 ; d) 2,5-비스(2-푸라닐)테트라하이드로푸란 ; e) 2,6-디메톡시-4(테트라하이드로-5-(3,4,5-트리메톡시페닐)-2-푸라닐)피리딘 ; f) 2,3-디메톡시-6-(테트라하이드로-5-(3,4,5-트리메톡시페닐)-2-푸라닐)피리딘 ; g)2,3,6-트리메톡시-5-(테트라이들-5-(34,5-트리메톡시페닐)-2-푸라닐)피리딘; 또는 h) 2-메톡시-4-(테트라하이드로-5-(3,4,5-트리메톡시페닐)-2-푸라닐)티아졸을 제조하는 방법.
  3. 제1항에 있어서, 다음과 같은 일반식으로 정의되는 화합물을 제조하는 방법.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860003097A 1985-04-22 1986-04-22 2, 5-디아릴테트 라하이드로푸란 및 이의 동족체, 이들의 제조방법 KR900003372B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72568785A 1985-04-22 1985-04-22
US725687 1985-04-22
US725,687 1985-04-22

Publications (2)

Publication Number Publication Date
KR860008157A true KR860008157A (ko) 1986-11-12
KR900003372B1 KR900003372B1 (ko) 1990-05-16

Family

ID=24915569

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860003097A KR900003372B1 (ko) 1985-04-22 1986-04-22 2, 5-디아릴테트 라하이드로푸란 및 이의 동족체, 이들의 제조방법

Country Status (12)

Country Link
EP (1) EP0199324B1 (ko)
JP (1) JPS6277A (ko)
KR (1) KR900003372B1 (ko)
AU (1) AU596969B2 (ko)
CA (1) CA1271759A (ko)
DE (1) DE3681751D1 (ko)
DK (1) DK181586A (ko)
ES (1) ES8801909A1 (ko)
GR (1) GR861044B (ko)
NZ (1) NZ215866A (ko)
PT (1) PT82430B (ko)
ZA (1) ZA862961B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010100A (en) * 1983-11-14 1991-04-23 Merck & Co. Inc. Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
GB2197650A (en) * 1986-11-21 1988-05-25 Merck & Co Inc Process for preparing 2,5-diphenyl tetrahydrofurans and analogs thereof
NZ227287A (en) * 1987-12-21 1992-01-29 Merck & Co Inc 2,5-diaryl tetrahydrofurans and medicaments
US4996203A (en) * 1987-12-21 1991-02-26 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5011847A (en) * 1989-06-08 1991-04-30 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5001123A (en) * 1989-06-08 1991-03-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5114961A (en) * 1989-06-08 1992-05-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US4977146A (en) * 1989-06-08 1990-12-11 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
GB9009469D0 (en) * 1990-04-27 1990-06-20 British Bio Technology Compounds
US5099033A (en) * 1990-06-29 1992-03-24 Merck & Co., Inc. Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as PAF antagonists
EP0465122A1 (en) * 1990-06-29 1992-01-08 Merck & Co. Inc. Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as paf antagonists
GB9114337D0 (en) * 1991-07-03 1991-08-21 British Bio Technology Compounds
GB9122308D0 (en) * 1991-10-21 1991-12-04 British Bio Technology Compounds
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
DK0650485T3 (da) * 1992-07-13 2001-01-22 Millennium Pharm Inc 2,5-Diaryltetrahydrothiophener, -furaner og analoger til behandling af inflammatoriske forstyrrelser og immunforstyrrelser
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
KR101965481B1 (ko) * 2016-10-25 2019-04-03 전북대학교산학협력단 쉬겔라 플렉스네리 및 살모넬라 엔터리티디스 검출용 펩타이드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769350A (en) * 1968-12-09 1973-10-30 Hoffmann La Roche Method for making 2,3-dimethyl-1,4-bis(3,4 - hydrocarbonyloxyphenyl) - 1,4-butanedione
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists

Also Published As

Publication number Publication date
KR900003372B1 (ko) 1990-05-16
AU596969B2 (en) 1990-05-24
PT82430B (pt) 1988-08-17
DK181586A (da) 1986-10-23
AU5643086A (en) 1986-10-30
GR861044B (en) 1986-08-25
JPS6277A (ja) 1987-01-06
CA1271759A (en) 1990-07-17
PT82430A (en) 1986-05-01
EP0199324A3 (en) 1988-02-10
EP0199324B1 (en) 1991-10-02
ZA862961B (en) 1986-12-30
EP0199324A2 (en) 1986-10-29
NZ215866A (en) 1989-11-28
ES8801909A1 (es) 1987-08-01
DE3681751D1 (de) 1991-11-07
ES554214A0 (es) 1987-08-01
DK181586D0 (da) 1986-04-21

Similar Documents

Publication Publication Date Title
KR860008157A (ko) 2.5-디아릴 테트라하이드로푸란 및 이의 동족체의 제조방법
FR2430940A1 (fr) Derives de cyanopyrrole, leur procede de preparation et application comme agents fongicides permettant le controle des champignons
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
US4476308B1 (ko)
KR830010039A (ko) 페닐 지방성 카복실린산 유도체의 제조방법
PT73841A (en) Process for preparing novel guanidine derivatives
KR840006481A (ko) 테트라졸화합물의 제조방법 및 이들화합물을 유효성분으로 하는 항균 및 항미 조성물
FR2514006B1 (ko)
SE8400458D0 (sv) Fungicidala kompositioner
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
HUT39741A (en) Process for preparing pyridine derivatives and pharmaceutical compositions containing such compounds as active ingredients
Elofson et al. Polarography of thioketones
SE8801945D0 (sv) New 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes
IL58774A (en) Fluorenyl-azolylmethylcarbinol compounds,their production and pharmaceutical compositions containing them
DE3264543D1 (en) Cyclic sulfenamides, process for their preparation, medicines containing them and preparation of the latter
FR2429211A1 (fr) Procede de production de derives de n-methylbenzothiazolone substitues en position 4
GB2175584A (en) Kojic acid derivatives and whitening cosmetics containing same
KR840005318A (ko) 살균제 조성물
SE8504119D0 (sv) 6-aminometyl-furo-(3,4-c)pyridinderivat, deras framsstellning och farmaceutiska kompositioner innehallande dem
KR870008871A (ko) 피리딘 유도체의 제조방법
SE8205837L (sv) Isopropylaminopyrimidinderivat, dess framstellning och terapeutiska kompositioner innehallande dessa
EP0414913A4 (en) P-aminophenol derivative and production and application thereof
JPS532476A (en) Synthesis of 4-substituted-dithio-2-azetidinone derivatives
IE801723L (en) N-acylamino oxazolidinones
ES8102568A1 (es) Metodo de preparar compuestos pirimidinicos con cabeza de puente de nitrogeno

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee